$3.03
-0.02-0.66%
마지막 업데이트: Oct 20, 8:52 AM
$2.97
-0.08-2.62%
Benzinga
Benzinga
Benzinga
목요일, 10월 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Addex Therapeutics (ADXN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-2.16 | $-1.53 | $-1.50 | $-1.50 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $12650 | $10214 | $20020 | $62500 |
| Surprise | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 4, 2021 | $-14.40 | $-14.40 | 0.00 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Sep 30, 2024 | $127.15K | $ | -51.1 % |
| Q3 | Nov 29, 2023 | $370.87K | $700.00K | -47.0 % |
| Q3 | Nov 4, 2021 | $825.37K | $420.00K | 96.5 % |